Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Journal of Clinical Medicine · 27.06.2023 · 12 (13) · 4323
DOI: 10.3390/jcm12134323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 27.06.2023. Verfasst von Maria Consuelo Pintado und 7 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Unit, Hospital Universitario Príncipe de Asturias, 28805 Alcalá de Henares, Spain. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ProA Capital, Halekulani S.L., MJR, European Development Regional Fund 'A way to achieve Europe', P2022/BMD-7321 (Comunidad de Madrid)..
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have benefits for survival in some cancers with peritoneal metastasis. Hematologic toxicity described rate is 2 to 38%.
Methods
Patients admitted to an intensive care unit (ICU) after CRS and HIPEC over 78 months. The data recorded were demographic characteristics, the severity of illness, complete blood samples, the type of cancer and extension, HIPEC drug and temperature, ICU and hospital stay and mortality, bleeding, and the need for transfusion of blood products.
Results
Of the 96 patients included, 77.1% presented hematological complications: 8.3% leukopenia (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Intensive Care Unit, Hospital Universitario Príncipe de Asturias, 28805 Alcalá de Henares, Spain.
- Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcalá, 28801 Alcalá de Henares, Spain.
- Department of General and Digestive Surgery, General and Digestive Surgery, Hospital Universitario Príncipe de Asturias, 28805 Alcalá de Henares, Spain.
- Ramón y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain.
- Inmune System Diseases-Rheumatology and Internal Medicine Service, Hospital Universitario Príncipe de Asturias (CIBEREHD), 28806 Alcalá de Henares, Spain.
ORCID-Profile: Maria Consuelo Pintado, Miguel A Ortega
Förderung
- ProA Capital, Halekulani S.L., MJR
- European Development Regional Fund 'A way to achieve Europe'
- P2022/BMD-7321 (Comunidad de Madrid).
- ProA Capital
- Halekulani S.L.
- MJR
- European Development Regional Fund “A way to achieve Europe”
- Comunidad de Madrid
Zitieren
APA
Pintado, M. C., Lasa Unzúe, I., Gómez Sanz, R., Diez Alonso, M., Ortega, M. A., Álvarez de Mon, M., Nevado Losada, E., & Gutierrez Calvo, A. (2023). Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Journal of Clinical Medicine, 12(13), 4323. https://doi.org/10.3390/jcm12134323
Vancouver
Pintado MC, Lasa Unzúe I, Gómez Sanz R, Diez Alonso M, Ortega MA, Álvarez de Mon M, et al. Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Journal of Clinical Medicine. 2023;12(13):4323. doi:10.3390/jcm12134323
BibTeX
@article{Pintado2023,
author = {Pintado, Maria Consuelo and Lasa Unzúe, Inmaculada and Gómez Sanz, Remedios and Diez Alonso, Manuel and Ortega, Miguel A and Álvarez de Mon, Melchor and Nevado Losada, Emilio and Gutierrez Calvo, Alberto},
title = {Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {13},
pages = {4323},
doi = {10.3390/jcm12134323}
}
EUVIMED